New York State Common Retirement Fund
PHAT icon

New York State Common Retirement Fund’s Phathom Pharmaceuticals PHAT Stock Holding History

New York State Common Retirement Fund’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Hold
10,770
– – ﹤0.01% 2601
2026
Q1 		$120K Sell
10,770
-30,986
-74% -$391K ﹤0.01% 2447
2025
Q4 		$693K Buy
41,756
+30,986
+288% +$443K ﹤0.01% 1836
2025
Q3 		$127K Hold
10,770
– – ﹤0.01% 2507
2025
Q2 		$103K Hold
10,770
– – ﹤0.01% 2599
2025
Q1 		$67.5K Hold
10,770
– – ﹤0.01% 2672
2024
Q4 		$87.5K Hold
10,770
– – ﹤0.01% 2653
2024
Q3 		$195K Hold
10,770
– – ﹤0.01% 2310
2024
Q2 		$111K Buy
10,770
+4,846
+82% +$49.9K ﹤0.01% 2697
2024
Q1 		$62.9K Buy
5,924
+137
+2% +$1.16K ﹤0.01% 2912
2023
Q4 		$52.8K Sell
5,787
-38
-0.7% -$327 ﹤0.01% 2977
2023
Q3 		$60.4K Buy
5,825
+159
+3% +$2.18K ﹤0.01% 2954
2023
Q2 		$81.1K Sell
5,666
-8,937
-61% -$103K ﹤0.01% 2997
2023
Q1 		$104K Hold
14,603
– – ﹤0.01% 2806
2022
Q4 		$164K Sell
14,603
-83
-0.6% -$856 ﹤0.01% 2804
2022
Q3 		$163K Buy
14,686
+150
+1% +$1.43K ﹤0.01% 2842
2022
Q2 		$123K Sell
14,536
-33
-0.2% -$339 ﹤0.01% 2993
2022
Q1 		$198K Hold
14,569
– – ﹤0.01% 2824
2021
Q4 		$287K Sell
14,569
-48
-0.3% -$1.13K ﹤0.01% 2729
2021
Q3 		$469K Sell
14,617
-2,878
-16% -$95.6K ﹤0.01% 2503
2021
Q2 		$592K Buy
17,495
+7,795
+80% +$279K ﹤0.01% 2507
2021
Q1 		$364K Hold
9,700
– – ﹤0.01% 2607
2020
Q4 		$322K Hold
9,700
– – ﹤0.01% 2561
2020
Q3 		$356K Hold
9,700
– – ﹤0.01% 2379
2020
Q2 		$319K Hold
9,700
– – ﹤0.01% 2439
2020
Q1 		$250K Hold
9,700
– – ﹤0.01% 2355
2019
Q4 		$302K Buy
+9,700
New +$244K ﹤0.01% 2538

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

New York State Common Retirement Fund's PHAT Position: Q2 2026 in Review

New York State Common Retirement Fund held its Phathom Pharmaceuticals (PHAT) position steady in Q2 2026 at 10,770 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #2601.

New York State Common Retirement Fund first reported a position in PHAT in Q4 2019 and has held it in 27 quarters since. The position peaked at $693K in Q4 2025. 161 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • New York State Common Retirement Fund held 10,770 shares of Phathom Pharmaceuticals worth $117K as of Q2 2026.
  • New York State Common Retirement Fund left its Phathom Pharmaceuticals share count unchanged in Q2 2026.
  • Phathom Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2601 holding.
  • New York State Common Retirement Fund first reported a position in Phathom Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • New York State Common Retirement Fund's Phathom Pharmaceuticals position peaked at $693K in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.